CN108042755A - It is a kind of to be used to treat weakness of the spleen and the stomach oral traditional Chinese medicine composition and its application - Google Patents
It is a kind of to be used to treat weakness of the spleen and the stomach oral traditional Chinese medicine composition and its application Download PDFInfo
- Publication number
- CN108042755A CN108042755A CN201810102227.5A CN201810102227A CN108042755A CN 108042755 A CN108042755 A CN 108042755A CN 201810102227 A CN201810102227 A CN 201810102227A CN 108042755 A CN108042755 A CN 108042755A
- Authority
- CN
- China
- Prior art keywords
- parts
- spleen
- stomach
- chinese medicine
- weakness
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8998—Hordeum (barley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
技术领域technical field
本发明属于中药技术领域,具体涉及一种用于治疗脾胃虚弱的内服中药组合物及其应用。The invention belongs to the technical field of traditional Chinese medicines, and in particular relates to an oral Chinese medicinal composition for treating weakness of the spleen and stomach and an application thereof.
背景技术Background technique
脾胃虚弱,为中医名词术语。脾胃虚弱含义比较笼统,包含了脾气虚、脾阳虚、脾不统血、中气下陷、胃阳虚、胃气虚、胃阴虚及脾胃虚寒等中医证候。其中脾气虚是脾胃虚弱的基本类型,脾气虚证是指脾气不足,失其健运所表现的证候。多因饮食不节,劳累过度,久病耗伤脾气所致。脾胃虚弱的常见临床表现:病程较长,泄泻时轻时重、或时发时止,大便稀溏,色淡无臭味,夹有不消化食物残渣,食后易泻,吃多后见腹胀、大便多,平素食欲不振,面色萎黄,神疲倦怠,形体瘦弱,舌质淡,苔薄白,脉虚无力。Weakness of the spleen and stomach is a term in traditional Chinese medicine. Deficiency of the spleen and stomach has a relatively general meaning, including TCM syndromes such as deficiency of the spleen, deficiency of spleen yang, failure of the spleen to control the blood, depression of middle qi, deficiency of stomach yang, deficiency of stomach qi, deficiency of stomach yin, and deficiency of spleen and stomach. Among them, deficiency of the spleen is the basic type of weakness of the spleen and stomach, and syndrome of deficiency of the spleen refers to the syndrome manifested by deficiency of the spleen and loss of its healthy movement. Mostly due to intemperance in diet, overwork, prolonged illness and injury of temper. Common clinical manifestations of weak spleen and stomach: long course of disease, diarrhea that can be mild or severe, or intermittent, loose and loose stools, light in color and odorless, with undigested food residues, easy diarrhea after eating, and see after eating too much Abdominal distension, frequent stools, loss of appetite, sallow complexion, fatigue, emaciated body, pale tongue, thin white fur, weak pulse.
采用中药复方对脾胃虚弱进行综合治疗是有效手段之一,治疗脾胃虚弱的内服中药复方的研发和发明对人类和社会具有十分重要意义。It is one of the effective means to comprehensively treat spleen and stomach weakness with traditional Chinese medicine compound. The development and invention of oral Chinese medicine compound for the treatment of spleen and stomach weakness is of great significance to human beings and society.
发明内容Contents of the invention
本发明解决的技术问题是提供一种对脾胃虚弱有显著疗效且无副作用的中药组合物及其应用。The technical problem to be solved by the present invention is to provide a traditional Chinese medicine composition which has significant curative effect on weak spleen and stomach and has no side effects and its application.
本发明的第一个目的是提供一种用于治疗脾胃虚弱的内服中药组合物,包括以下重量份数的原料组分:太子参9~21份、白术6~14份、茯苓15~35份、焦三仙各18~42份、鸡内金9~21份、木香6~14份、砂仁6~14份、甘草3~7份。The first object of the present invention is to provide an oral Chinese medicine composition for treating weakness of the spleen and stomach, comprising the following raw material components in parts by weight: 9-21 parts of Radix Pseudostellariae, 6-14 parts of Atractylodes Rhizome, 15-35 parts of Poria cocos , 18-42 parts of Jiao Sanxian, 9-21 parts of Chicken Neijin, 6-14 parts of Muxiang, 6-14 parts of Amomum, and 3-7 parts of Licorice.
优选地,本发明提供放入用于治疗脾胃虚弱的内服中药组合物,包括以下重量份数的原料组分:太子参15份、白术10份、茯苓25份、焦三仙各30份、鸡内金15份、木香10份、砂仁10份、甘草5份。Preferably, the present invention provides an oral Chinese medicine composition for treating weakness of the spleen and stomach, including the following raw material components in parts by weight: 15 parts of Radix Pseudostellariae, 10 parts of Atractylodes Rhizoma Atractylodes Rhizome, 25 parts of Poria cocos, 30 parts of Jiaosanxian, Gallus gallis 15 parts, woody 10 parts, amomum 10 parts, licorice 5 parts.
优选地,所述焦三仙为焦麦芽、焦山楂和焦神曲。Preferably, the Jiaosanxian is Jiaomaiya, Jiaohazha and Jiaoshenqu.
本发明的第二个目的是提供上述用于治疗脾胃虚弱的内服中药组合物在制备脾胃虚弱药物制剂中的应用。The second object of the present invention is to provide the application of the above-mentioned oral Chinese medicine composition for treating weakness of the spleen and stomach in the preparation of pharmaceutical preparations for weakness of the spleen and stomach.
优选地,所述药物制剂的药用剂型为片剂、胶囊剂、颗粒剂、分散片剂或丸剂。Preferably, the pharmaceutical dosage form of the pharmaceutical preparation is tablet, capsule, granule, dispersible tablet or pill.
本发明的第四个目的是提供上述用于治疗脾胃虚弱的内服中药组合物在制备食品、化妆品、洗涤用品或牙膏中的应用。The fourth object of the present invention is to provide the application of the above-mentioned oral Chinese medicine composition for treating weakness of the spleen and stomach in the preparation of food, cosmetics, washing products or toothpaste.
本发明组合物中各组分的药理作用:The pharmacological action of each component in the composition of the present invention:
太子参为君药,味甘、微苦,性平;入心、脾、肺三经。能补气益脾,养阴生津。白术为臣药,健脾、燥湿,以助运化,和太子参,以增强太子参的益气健脾之功。佐药为茯苓渗湿健脾,苓术合用,促进健脾除湿和运化之力的增强;焦三仙,即焦麦芽、焦山楂、焦神曲。这三味药均有良好的消积化滞功能,但又有各自不同的特点。焦麦芽有很好的消化淀粉类食物的作用;焦山楂善于治疗肉类或油腻过多所致的食滞;焦神曲则利于消化米面食物;三药合用,能明显地增强消化功能。鸡内金甘,寒。归脾、胃、小肠、膀胱经,消食健胃助消化,涩精止遗。可以促进胃液分泌,提高胃酸度及消化力,使胃运动功能明显增强,胃排空加快。使药为木香味辛、苦,性温;归脾、胃、肝、大肠经,芳香行散,可升可降;行气止痛,理气疏肝,健脾消滞。砂仁味辛,性温;归脾经、胃经、肾经;化湿开胃,温脾止泻,理气安胎。甘草,甘温,能调诸药,让它们共同发挥补气健脾的效果。诸药合用益气健脾,消食导滞;用于脾胃气虚,胃纳不佳之腹胀纳呆,食少便溏,气短乏力。Pseudostellaria Pseudostellariae is a monarch drug, sweet in taste, slightly bitter, and flat in nature; it enters the three meridians of the heart, spleen, and lung. Can invigorate qi and spleen, nourish yin and promote fluid. Atractylodes macrocephala is a ministerial drug, which invigorates the spleen, dries dampness, and aids in transportation and transformation, and Pseudostellariae Radix Pseudostellariae, to enhance the effect of Pseudostellariae Radix Pseudostellariae on invigorating Qi and invigorating the spleen. The adjuvant medicine is Poria for removing dampness and invigorating the spleen, combined with Lingzhu to promote the strengthening of spleen and dehumidification and the power of transportation and transformation; Jiao Sanxian, that is, Jiao Maiya, Jiao Hawthorn, and Jiao Shenqu. These three medicines all have a good function of eliminating stagnation and stagnation, but they have different characteristics. Burnt malt has a good effect on digesting starchy foods; Jiaoshanzha is good at treating food stagnation caused by too much meat or greasy food; Jiao Shenqu is good for digesting rice and noodles; the combination of the three medicines can significantly enhance digestion. The chicken is golden sweet, cold. Return spleen, stomach, small intestine, bladder meridian, promote digestion, invigorate the stomach and help digestion, astringent essence to stop nocturnal emission. It can promote the secretion of gastric juice, increase gastric acidity and digestion, significantly enhance gastric motility, and accelerate gastric emptying. The medicine is woody fragrance pungent, bitter, warm in nature; it returns to the spleen, stomach, liver, and large intestine meridian, and the fragrance is dispersed, which can rise and fall; promote qi and relieve pain, regulate qi and soothe the liver, strengthen the spleen and eliminate stagnation. Amomum is pungent in taste and warm in nature; it belongs to the spleen, stomach, and kidney meridians; it removes dampness and appetizers, warms the spleen and relieves diarrhea, regulates qi and relieves miscarriage. Licorice, sweet and warm, can regulate various medicines and make them work together to invigorate Qi and strengthen the spleen. All medicines are used in combination to invigorate qi and invigorate the spleen, promote digestion and guide stagnation; it is used for abdominal distension and loss of appetite due to deficiency of spleen and stomach qi, poor appetite, lack of appetite, loose stools, shortness of breath and fatigue.
与现有技术相比,本发明的有益效果在于:Compared with prior art, the beneficial effect of the present invention is:
本发明提供的用于治疗脾胃虚弱的内服中药组合物,疗效显著且无任何副作用,不仅可以用于治疗脾胃虚弱药物的制备,还可作为食疗药物加工成食品或应用到化妆品、洗涤用品、牙膏的制备过程中。The oral Chinese medicine composition for treating weakness of the spleen and stomach provided by the present invention has significant curative effect and no side effects, and can not only be used for the preparation of medicines for treating weakness of the spleen and stomach, but also can be processed into food as a dietotherapy medicine or applied to cosmetics, washing products and toothpaste in the preparation process.
具体实施方式Detailed ways
为了使本领域技术人员更好地理解本发明的技术方案能予以实施,下面结合具体实施例对本发明作进一步说明,但所举实施例不作为对本发明的限定。In order to enable those skilled in the art to better understand that the technical solutions of the present invention can be implemented, the present invention will be further described below in conjunction with specific examples, but the given examples are not intended to limit the present invention.
下面各实施例中未注明具体条件的试验方法,均按照本领域的常规方法和条件进行,所用原料均为市售。The test methods that do not indicate specific conditions in the following examples are all carried out according to conventional methods and conditions in this area, and the raw materials used are all commercially available.
实施例1Example 1
本实施例一种用于治疗脾胃虚弱的内服中药组合物,包括以下重量份数的原料组分:太子参15份、白术10份、茯苓25份、焦三仙各30份、鸡内金15份、木香10份、砂仁10份、甘草5份。In this embodiment, an oral Chinese medicine composition for treating weakness of the spleen and stomach includes the following raw material components in parts by weight: 15 parts of Radix Pseudostellariae, 10 parts of Atractylodes Rhizoma Atractylodes Rhizome, 25 parts of Poria cocos, 30 parts of Jiao Sanxian each, 15 parts of Gallus gallis, 10 parts of woody fragrance, 10 parts of amomum, 5 parts of licorice.
上述中药组合物的制备过程非常简单,将各原料组分按比例称取后,分别进行粉碎,粉碎后的原料混合均匀,按照药用制剂的常规生产工艺进行制备制成片剂。The preparation process of the above-mentioned traditional Chinese medicine composition is very simple. After weighing each raw material component in proportion, they are respectively pulverized, and the pulverized raw materials are mixed evenly, and prepared into tablets according to the conventional production process of pharmaceutical preparations.
实施例2Example 2
本实施例一种用于治疗脾胃虚弱的内服中药组合物,包括以下重量份数的原料组分:太子参9份、白术8份、茯苓15份、焦三仙各20份、鸡内金9份、木香6份、砂仁6份、甘草4份。In this embodiment, an oral Chinese medicine composition for treating weakness of the spleen and stomach includes the following raw material components in parts by weight: 9 parts of Radix Pseudostellariae, 8 parts of Atractylodes Rhizoma Atractylodes Rhizome, 15 parts of Poria cocos, 20 parts of Jiao Sanxian each, 9 parts of Gallus gallis, 6 parts of woody fragrance, 6 parts of amomum, 4 parts of licorice.
将上述各原料组分按比例称取后,分别进行粉碎,粉碎后的原料混合均匀,按照药用制剂的常规生产工艺进行制备制成胶囊剂。After the above-mentioned raw material components are weighed in proportion, they are respectively pulverized, and the pulverized raw materials are mixed evenly, and prepared into capsules according to the conventional production process of pharmaceutical preparations.
实施例3Example 3
本实施例一种用于治疗脾胃虚弱的内服中药组合物,包括以下重量份数的原料组分:太子参21份、白术14份、茯苓30份、焦三仙各42份、鸡内金18份、木香14份、砂仁14份、甘草7份。In this embodiment, an oral Chinese medicine composition for treating weakness of the spleen and stomach comprises the following raw material components in parts by weight: 21 parts of Radix Pseudostellariae, 14 parts of Atractylodes Rhizoma Atractylodes Rhizome, 30 parts of Poria cocos, 42 parts of Jiao Sanxian each, 18 parts of Gallus gallis, 14 parts of woody fragrance, 14 parts of amomum, 7 parts of licorice.
将上述各原料组分按比例称取后,分别进行粉碎,粉碎后的原料混合均匀,按照药用制剂的常规生产工艺进行制备制成颗粒剂。After the above-mentioned raw material components are weighed in proportion, they are pulverized respectively, and the pulverized raw materials are mixed evenly, and are prepared into granules according to the conventional production process of pharmaceutical preparations.
实施例4Example 4
本实施例一种用于治疗脾胃虚弱的内服中药组合物,包括以下重量份数的原料组分:太子参18份、白术10份、茯苓35份、焦三仙各25份、鸡内金21份、木香12份、砂仁12份、甘草3份。In this embodiment, an oral Chinese medicine composition for treating weakness of the spleen and stomach comprises the following raw material components in parts by weight: 18 parts of Radix Pseudostellariae, 10 parts of Atractylodes Rhizoma Atractylodes Rhizome, 35 parts of Poria cocos, 25 parts of Jiaosanxian each, 21 parts of Gallus gallis, 12 parts of woody fragrance, 12 parts of amomum, 3 parts of licorice.
将上述各原料组分按比例称取后,分别进行粉碎,粉碎后的原料混合均匀,按照药用制剂的常规生产工艺进行制备制成丸剂。After the above-mentioned raw material components are weighed in proportion, they are pulverized respectively, and the pulverized raw materials are mixed evenly, and prepared into pills according to the conventional production process of pharmaceutical preparations.
实施例1~4均制备出了效果良好的用于治疗脾胃虚弱的制剂,由于实施例1~4制备出的用于治疗脾胃虚弱的制剂效果基本平行,因此仅采用实施例1制备出的中药制剂来对本发明的效果进行说明。Examples 1 to 4 have all prepared preparations for treating weakness of the spleen and stomach with good effects. Since the effects of the preparations prepared in Examples 1 to 4 for treating weakness of the spleen and stomach are basically parallel, only the traditional Chinese medicine prepared in Example 1 is used. Preparations are used to illustrate the effects of the present invention.
以下采用动物试验和临床试验来进一步对本发明的效果进行说明。The effects of the present invention will be further described by adopting animal experiments and clinical trials below.
一、动物试验1. Animal experiments
1、急性毒性实验1. Acute toxicity test
应用NIH小鼠60只,SPF级,雌雄各半,体重18-22g,进行急性毒性试验。小鼠随机分为两组,每组30只,即对照组和给药组,实验前禁食12小时;将本发明的实施例1制备治疗脾胃虚弱的片剂溶解在水中,(浓度为6g生药/mL,最高浓度)灌胃,灌胃容积为5mL/kg(即单次给药剂量为30g生药/kg),对照组给予等量生理盐水,一天给药2次,给药间隔时间6小时,给药后连续观察14天,并记录小鼠的的毒性反应及死亡数。60 NIH mice, SPF grade, half male and half male, weighing 18-22g, were used for acute toxicity test. Mice are divided into two groups at random, every group of 30, i.e. control group and administration group, fasting 12 hours before experiment; The tablet that the embodiment of the present invention 1 is prepared to treat weak spleen and stomach is dissolved in water, (concentration is 6g Crude drug/mL, the highest concentration) by gavage, the volume of gavage is 5mL/kg (that is, the single dose is 30g crude drug/kg), the control group is given the same amount of normal saline, administered twice a day, with an interval of 6 Hours, continuous observation for 14 days after administration, and record the number of toxic reactions and deaths of the mice.
实验结果表明:与对照组比较,给药后小鼠未见明显差异,实验连续观察14天,小鼠全身状况、饮食、饮水、体重增长均正常。小鼠口服灌胃本发明治疗脾胃虚弱的片剂LD50>30g生药/kg,每日最大给药量为60g生药/kg/日。本发明实施例1制备的中药制剂临床用药量为12g生药/日/人,成人体重以60kg计,平均用药剂量为0.2g生药/kg/日。按体重计:小鼠(平均体重以20g计)口服灌胃本发明的中药制剂的耐受量为临床用量的300倍。因此本发明的中药制剂急性毒性低,临床用药安全。The results of the experiment showed that compared with the control group, there was no significant difference in the mice after administration. After 14 days of continuous observation in the experiment, the general condition, diet, drinking water, and weight gain of the mice were all normal. Mice are orally gavaged. The tablet LD50 of the present invention for treating weakness of the spleen and stomach is greater than 30g crude drug/kg, and the maximum daily dosage is 60g crude drug/kg/day. The clinical dosage of the traditional Chinese medicine preparation prepared in Example 1 of the present invention is 12g crude drug/day/person, and the adult body weight is 60kg, and the average dosage is 0.2g crude drug/kg/day. By body weight: the tolerated dose of the traditional Chinese medicine preparation of the present invention is 300 times that of the clinical dosage in mice (average body weight in 20 g). Therefore, the traditional Chinese medicine preparation of the present invention has low acute toxicity and is safe for clinical use.
2、长期毒性实验2. Long-term toxicity test
本发明实施例1制备治疗脾胃虚弱的片剂对小鼠按10.02g、20.35g和33.48g生药/kg连续用药10周(1.0mL/100g体重,每天2次)及停药4周后对小鼠进行观察、检测。The embodiment of the present invention 1 prepares the tablet for the treatment of weakness of the spleen and stomach to mice by 10.02g, 20.35g and 33.48g crude drug/kg continuous medication for 10 weeks (1.0mL/100g body weight, 2 times a day) and after drug withdrawal for 4 weeks to mice Rats were observed and tested.
实验结果表明:本发明实施例1制备的用于治疗脾胃虚弱的片剂对大鼠的毛发、行为、大小便、体重、脏器重量、血象、肝肾功能、血糖、血脂等指标均无明显影响,脏器肉眼没有发现异样变化和组织学检查结果表明,用药10周及停药4周后,大鼠各脏器均无明显改变。说明本发明实施例1制备治疗脾胃虚弱的片剂对大鼠长期用药后毒性小,停药后也没有异样反应,应用安全。The experimental results show that: the tablet prepared in Example 1 of the present invention for treating weakness of the spleen and stomach has no significant effect on the hair, behavior, urine and stool, body weight, organ weight, blood picture, liver and kidney function, blood sugar, blood lipids and other indicators of rats. No abnormal changes were found in the viscera with the naked eye, and the results of histological examination showed that after 10 weeks of medication and 4 weeks after drug withdrawal, there was no obvious change in each organ of the rat. It shows that the tablet prepared in Example 1 of the present invention for treating weakness of the spleen and stomach has little toxicity to rats after long-term administration, and there is no abnormal reaction after drug withdrawal, so the application is safe.
二、临床试验2. Clinical trials
1、临床案例1. Clinical cases
确诊的脾胃虚弱症者为研究试验对象,选取95例临床病例,其中男性58例,女性37例,年纪最大69岁,最小27岁,志愿者必须符合《中医虚症辩证参考标准》的要求确诊为脾胃虚弱症,其他患者不能参与本实验。Diagnosed patients with weakness of the spleen and stomach were the subjects of the study. 95 clinical cases were selected, including 58 males and 37 females. The oldest was 69 years old and the youngest was 27 years old. Spleen and stomach weakness, other patients cannot participate in this experiment.
2、治疗方法2. Treatment method
治疗期间服用本发明实施例1制备出的片剂,温水送服,每日早晚各服用一次,一次2片,一片3g,治疗周期为4周。Take the tablet prepared by the embodiment of the present invention 1 during the treatment period, take it with warm water, take it once every morning and evening, 2 tablets at a time, 3g per tablet, and the treatment cycle is 4 weeks.
3、治疗效果评价:3. Evaluation of treatment effect:
显效:治疗后症状较治疗前明显减少,各项检查指标基本恢复正常。Significantly effective: After treatment, the symptoms were significantly reduced compared with those before treatment, and all inspection indicators basically returned to normal.
有效:治疗后症状有所减少,各项指标改善。Effective: After treatment, the symptoms were reduced, and various indicators were improved.
无效:治疗后各症状无明显改善。Ineffective: After treatment, the symptoms did not improve significantly.
4、实验结果4. Experimental results
95例患者中痊愈的71例,显效的24例,总有效率达100%,经治疗一个疗程(4周)后,症除而愈。Of the 95 patients, 71 were cured and 24 were markedly effective, with a total effective rate of 100%. After a course of treatment (4 weeks), the symptoms were eliminated and healed.
5、典型病例5. Typical cases
(1)脾气虚病例:男,45岁,经诊断脘腹胀满,食后为甚,口不知味,甚至不思饮食,大便溏薄,精神不振,形体消瘦,肢体倦怠,少气懒言,面色萎黄或白,或肢体浮肿,舌淡苔白,脉缓弱无力。服用其它治疗药物未见好转,服用本发明实施例1制备治疗脾胃虚弱的片剂共5天后,上述症状消失。(1) Spleen Qi Deficiency Case: Male, 45 years old, was diagnosed with fullness in the abdomen and abdomen, especially after eating, no taste in the mouth, even no desire to eat, loose stools, lack of energy, emaciated body, tired limbs, lack of energy and laziness to speak, Pale or pale complexion, or swollen limbs, pale tongue with white fur, slow and weak pulse. Taking other therapeutic drugs did not improve, and after taking the tablet prepared by Example 1 of the present invention for treating weakness of the spleen and stomach for 5 days, the above symptoms disappeared.
(2)脾阳虚病例:女,27岁,腹胀纳少,腹痛绵绵,喜温喜按,形寒肢冷,大便溏薄清稀,白带多质稀,舌质淡胖,苔白滑,脉沉迟无力。服用本发明实施例1制备治疗脾胃虚弱的片剂共3天后,症状缓解,继续服用4天,诸症消失。(2) Spleen Yang Deficiency Cases: Female, 27 years old, with abdominal distension, anorexia, continuous abdominal pain, warm and pressing, cold and cold extremities, loose stools, thin and thin leucorrhea, pale and fat tongue, white and slippery fur, The pulse is slow and weak. After taking the tablet prepared by Example 1 of the present invention for treating weakness of the spleen and stomach for 3 days, the symptoms were relieved, and continued to take for 4 days, and all symptoms disappeared.
(3)中气下陷病例:男,30岁,面色淡白,眩晕易汗,短气,倦怠,食少,便溏、腹部重坠,便意频数。服用本发明实施例1制备治疗脾胃虚弱的片剂共6天后,进食量增加,大便正常,腹部坠胀感消失。(3) Cases of subsidence of Qi: male, 30 years old, pale complexion, dizzy and prone to sweating, shortness of breath, fatigue, lack of appetite, loose stools, heavy abdomen, frequent defecation. After taking the tablet prepared by Example 1 of the present invention for treating weakness of the spleen and stomach for 6 days, the food intake increased, the stool was normal, and the feeling of abdominal distension disappeared.
(4)脾不统血病例:女,31岁,食少,腹胀,便溏,肢体倦怠,少气懒言,面色萎黄,月经过多,舌淡苔白,脉缓弱。服用本发明实施例1制备治疗脾胃虚弱的片剂共5天后诸症均消。(4) Case of spleen not controlling blood: Female, 31 years old, lack of food, abdominal distension, loose stools, body fatigue, lack of breath, lazy to speak, sallow complexion, menorrhagia, pale tongue with white coating, slow and weak pulse. All symptoms disappeared after taking the tablet prepared by Example 1 of the present invention for treating weakness of the spleen and stomach for 5 days.
(5)脾阴虚病例:男,30岁,口干唇燥,嘈杂,干呕,饮食减少,或吞咽不利,食后胸膈不适,大便干结,舌红中心干,少苔,脉细数等。服用本发明实施例1制备治疗脾胃虚弱的片剂共4天后,诸症消失。(5) Cases of spleen-yin deficiency: male, 30 years old, dry mouth and lips, noisy, retching, reduced diet, or difficulty swallowing, chest and diaphragm discomfort after eating, dry stool, red tongue with dry center, little coating, thready pulse Wait. After taking the tablet prepared by Example 1 of the present invention for treating weakness of the spleen and stomach for 4 days, all symptoms disappeared.
综上,本发明所述的中药组方合理、成本低、药物取材方便、制剂简易、疗程短、疗效显著、治愈率高、无毒副作用。To sum up, the traditional Chinese medicine of the present invention has reasonable prescriptions, low cost, convenient drug materials, simple preparation, short course of treatment, significant curative effect, high cure rate, and no toxic or side effects.
需要说明的是,本发明权利要求书中涉及数值范围时,应理解为每个数值范围的两个端点以及两个端点之间任何一个数值均可选用,由于采用的步骤方法与实施例1-4相同,为了防止赘述,本发明的描述了优选的实施例,但本领域内的技术人员一旦得知了基本创造性概念,则可对这些实施例作出另外的变更和修改。所以,所附权利要求意欲解释为包括优选实施例以及落入本发明范围的所有变更和修改。It should be noted that when a numerical range is involved in the claims of the present invention, it should be understood that the two endpoints of each numerical range and any value between the two endpoints can be selected, because the steps and methods adopted are the same as those in Embodiment 1- 4 Similarly, to avoid repetition, the present invention describes preferred embodiments, but those skilled in the art can make additional changes and modifications to these embodiments once the basic inventive concepts are known. Therefore, it is intended that the appended claims be construed to cover the preferred embodiment as well as all changes and modifications which fall within the scope of the invention.
显然,本领域的技术人员可以对本发明进行各种改动和变型而不脱离本发明的精神和范围。这样,倘若本发明的这些修改和变型属于本发明权利要求及其等同技术的范围之内,则本发明也意图包含这些改动和变型在内。Obviously, those skilled in the art can make various changes and modifications to the present invention without departing from the spirit and scope of the present invention. Thus, if these modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalent technologies, the present invention also intends to include these modifications and variations.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810102227.5A CN108042755A (en) | 2018-02-01 | 2018-02-01 | It is a kind of to be used to treat weakness of the spleen and the stomach oral traditional Chinese medicine composition and its application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810102227.5A CN108042755A (en) | 2018-02-01 | 2018-02-01 | It is a kind of to be used to treat weakness of the spleen and the stomach oral traditional Chinese medicine composition and its application |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108042755A true CN108042755A (en) | 2018-05-18 |
Family
ID=62125583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810102227.5A Pending CN108042755A (en) | 2018-02-01 | 2018-02-01 | It is a kind of to be used to treat weakness of the spleen and the stomach oral traditional Chinese medicine composition and its application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108042755A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110090282A (en) * | 2019-03-27 | 2019-08-06 | 中国中医科学院西苑医院 | For mitigating the Chinese medicine composition of gastrointestinal tract toxicity |
CN110624066A (en) * | 2019-11-05 | 2019-12-31 | 宋小冰 | Traditional Chinese medicine for treating infantile anorexia |
CN115944699A (en) * | 2022-12-14 | 2023-04-11 | 修正药业集团股份有限公司 | Traditional Chinese medicine composition with effects of activating spleen, tonifying qi, promoting digestion and removing food stagnation as well as preparation method and application thereof |
CN117298232A (en) * | 2023-08-21 | 2023-12-29 | 广西国际壮医医院 | Graphene electrothermal film spleen-strengthening navel dressing composition for treating infantile diarrhea and preparation and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105362906A (en) * | 2015-11-29 | 2016-03-02 | 王宁 | Traditional Chinese medicine for treating spleen-stomach deficiency and food stagnation symptoms of children and method for preparing traditional Chinese medicine |
-
2018
- 2018-02-01 CN CN201810102227.5A patent/CN108042755A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105362906A (en) * | 2015-11-29 | 2016-03-02 | 王宁 | Traditional Chinese medicine for treating spleen-stomach deficiency and food stagnation symptoms of children and method for preparing traditional Chinese medicine |
Non-Patent Citations (2)
Title |
---|
孙世发等: "《中华医方 内科篇 脾系病》", 28 February 2015, 科学技术文献出版社 * |
郭建生等: "《实用临床中药手册》", 31 August 2016, 湖南科学技术出版社 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110090282A (en) * | 2019-03-27 | 2019-08-06 | 中国中医科学院西苑医院 | For mitigating the Chinese medicine composition of gastrointestinal tract toxicity |
CN110624066A (en) * | 2019-11-05 | 2019-12-31 | 宋小冰 | Traditional Chinese medicine for treating infantile anorexia |
CN115944699A (en) * | 2022-12-14 | 2023-04-11 | 修正药业集团股份有限公司 | Traditional Chinese medicine composition with effects of activating spleen, tonifying qi, promoting digestion and removing food stagnation as well as preparation method and application thereof |
CN117298232A (en) * | 2023-08-21 | 2023-12-29 | 广西国际壮医医院 | Graphene electrothermal film spleen-strengthening navel dressing composition for treating infantile diarrhea and preparation and application thereof |
CN117298232B (en) * | 2023-08-21 | 2024-08-23 | 广西国际壮医医院 | Graphene electrothermal film spleen-strengthening navel dressing composition for treating infantile diarrhea and preparation and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108042755A (en) | It is a kind of to be used to treat weakness of the spleen and the stomach oral traditional Chinese medicine composition and its application | |
CN105028995A (en) | Mixed dog food and preparation method thereof | |
US20230125425A1 (en) | Traditional chinese medicine extract composition with function of regulating depressive emotion and preparation method and traditional chinese medicine preparation thereof | |
CN107320555A (en) | A kind of pharmaceutical composition with antifatigue effect and its production and use | |
CN106913626B (en) | A kind of pharmaceutical composition for treating enterogastritis and preparation method thereof, preparation and application | |
CN104436247A (en) | Contrast agent for detecting gastrointestinal diseases by ultrasonic wave and preparation method thereof | |
CN104001131A (en) | Oral traditional Chinese medicine for preventing and treating stress ulcers | |
JPH04243834A (en) | Pharmaceutical composition | |
CN102552743A (en) | Medicinal composition for treating diabetes and preparation method thereof | |
CN101816708B (en) | Chinese medicinal composition for curing rheumatism and preparation method thereof | |
CN112089783B (en) | Application of traditional Chinese medicine composition in the preparation of medicine for preventing or/and treating obesity | |
CN104784650A (en) | Pharmaceutical preparation for clinical nursing of gastric ulcer | |
CN104435669A (en) | Traditional Chinese medicine composition for treating septic shock and accompanying multi-organ dysfunction syndrome | |
TW202019455A (en) | Composition for tonifying kidney and strengthening Yang and preparation method and use thereof | |
CN115414439B (en) | A kind of traditional Chinese medicine composition for treating functional constipation | |
CN103432502B (en) | A kind of Chinese patent medicine for the treatment of peptic ulcer disease | |
CN101104066A (en) | Traditional Chinese medicine composition for treating cold syndrome of disease of acid regurgitation | |
CN108578473A (en) | A kind of drug and preparation method thereof for treating stomachache | |
CN102631496B (en) | Traditional Chinese medicine composition capable of improving immunity and resisting fatigue | |
CN107260851A (en) | A kind of Chinese medicine composition for treating weakness constipation | |
CN104888129A (en) | Traditional Chinese medicine composition for treating chest stuffiness and pain and hyperlipidemia and application of traditional Chinese medicine composition | |
CN1209139C (en) | Traditional Chinese medicine for curing vascular dementia and its preparing method | |
CN1861119B (en) | Traditional Chinese medicine for treating rheumatosis and its preparation method | |
CN119454867A (en) | A Chinese medicinal composition with weight reducing effect, and its preparation method | |
CN106309926A (en) | Composition prepared from bee products and medical and edible dual-purpose food and used for treating gastritis and gastric ulcer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180518 |
|
RJ01 | Rejection of invention patent application after publication |